Clinical Trial Update: Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions [Phase 3]

View source ↗

Summary

Phase 3 trial investigating bleomycin, doxycycline, or talc for treating malignant pleural effusions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Metastatic Cancer | Phase 3 | Status: COMPLETED